Manufacturing

Manufacturing

R-Pharm’s production designed with account to all latest GMP requirements, which is unprecedented for Russia, especially for the production of aseptic injection drug formulations.

Новости

R-Pharm Signs Memorandum of Cooperation with Ministry of Healthcare of Belarus

news

R-Pharm Signs Memorandum of Cooperation with Ministry of Healthcare of Belarus

April 7, 2015

R-Pharm Group of Companies Continues Development of New Generation Antibiotic

news

In 2012 Theravance, Inc., an American pharma company, and R-Pharm, a Russian group of companies, announced conclusion of agreement on development and commercialization of antimicrobials. No later than in 2015 an innovative antibiotic that belongs to lipoglycopeptide group with the trade name of Vibativ (international non-patented name is telavancin) is expected to be registered in the Russian market. It is used in the USA and Europe for treatment of gram-positive complicated skin and soft tissue infections.

March 18, 2015

R-Pharm Organizes Pharma Festival for Yaroslavl Schoolchildren

R-Pharm Organizes Pharma Festival  for Yaroslavl Schoolchildren

On March 12h and 13th in Yaroslavl there took place a themed festival for primary school-aged children organized by R-Pharm group of companies.

March 16, 2015

Bristol-Myers Squibb and R-Pharm Announce Start-Up of a New Project on Localization of Production Stage of Innovative Drug for Chronic Myeloid Leukemia Treatment

news

March 11th, 2015, Moscow: Bristol-Myers Squibb and R-Pharm group of companies have concluded a licensed agreement on localization of production of SPRAYSEL® (Dazatinib), an innovative drug for targeted antitumor therapy, at the R-Pharm facilities.

March 11, 2015

Congratulations on International Women’s Day!

Congratulations on International Women’s Day!

March 7, 2015
News Archive →